PBM Delinking Legislation Could Reshape Medicaid MCO Pharmacy Contracting Models

Federal proposals to prohibit PBMs from earning compensation tied to drug prices or manufacturer rebates—requiring instead flat service fees—could fundamentally change how Medicaid managed care plans contract for pharmacy benefit management. While delinking bills have focused primarily on Medicare Part D and commercial markets, the policy shift would affect PBM operations across all lines of business including Medicaid, potentially altering incentive structures that currently encourage deeper manufacturer discounts. MCOs would need to evaluate how mandatory flat-fee arrangements impact their ability to maximize drug rebates and manage pharmacy costs under capitated payment models.

Pharmacy · Managed Care

This is outside commentary from Avalere, not part of Medicaid Monitor's independently scored news coverage.

More from Avalere